<DOC>
	<DOCNO>NCT02281929</DOCNO>
	<brief_summary>Treatment reference severe alcoholic hepatitis base corticosteroid , give 28 day . However , 25-35 % patient take benefit treatment die within 6 month follow diagnosis . Numerous trial evaluate impact several strategy association corticosteroid . None show improvement survival ( primary endpoint ) compare corticosteroid alone . The project base approach never test randomize control trial severe alcoholic hepatitis , target group patient high risk death ( 25-35 % 2 month ) . This approach base animal human studies.Antibiotics effective animal model circumstance characterize liver failure gastrointestinal bleeding related portal hypertension . The interest study population emphasize frequency infection critically ill patient . Antibiotics administer development infection , likely patient present mesenteric bacterial adenitis without systemic sign infection . Primary endpoint 2-month survival death occur within 60 day treatment give 30 day .</brief_summary>
	<brief_title>Efficacy Antibiotic Therapy Severe Alcoholic Hepatitis Treated With Prednisolone</brief_title>
	<detailed_description>This multicenter double-blind randomize control study two parallel group . Once inclusion exclusion criterion verify obtained patient write consent , participative center process inclusion trial . Corticosteroids well antibiotic placebo start orally . Patients manage hospital unit day 7 , correspond evaluation response treatment use Lille model . After 7-day period , patient followed-up day 14 , day 21 , day 30 , day 60 ( primary endpoint ) . During visit , biological clinical feature include efficacy tolerance assess well presence infection hepatorenal syndrome ( secondary endpoint ) .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Hepatitis , Alcoholic</mesh_term>
	<mesh_term>Liver Diseases , Alcoholic</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Patients age 1875 Recent onset jaundice ( &lt; 3 month ) Biopsy proven alcoholic hepatitis ( transjugular liver biopsy ) Maddrey 's discriminant function ≥ 32 , define severe alcoholic hepatitis MELD score ≥21 Alcohol consumption ≥ 40g/day ( woman ) ≥ 50g/day ( men ) Written inform consent Previous severe allergy hypersensitivity amoxicillin clavulanic acid ( anaphylactic shock , Quincke edema , severe urticaria ) Hypersensitivity component medication History liver injury amoxicillin and/or clavulanic acid Phenylketonuria , presence aspartame powder oral suspension Type 1 hepatorenal syndrome initiation treatment Severe extrahepatic disease Any malignant tumor &lt; 2 year Uncontrolled gastrointestinal bleeding Ongoing viral parasitic infection Untreated bacterial infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Alcoholic hepatitis</keyword>
	<keyword>corticotherapy</keyword>
	<keyword>antibiotherapy</keyword>
	<keyword>survival</keyword>
	<keyword>infection</keyword>
	<keyword>hepato renal syndrome</keyword>
</DOC>